Anima
- Address
- lock Available on a paid plan
Female Urogenital Health and Menopause-Related Care
At Anima in the Pneumology department, clinical research is focused on female urogenital diseases and pregnancy complications, with a specific emphasis on sleep disturbances associated with menopause. The trials are designed to better understand this condition and assess whether new approaches can help improve sleep and related symptoms in affected women.
- Menopause-related sleep disturbances
- Female urogenital diseases
- Evaluating a new therapy for symptom relief
Research at this site is centered on improving care for women experiencing menopause-linked sleep problems, with attention to both treatment effectiveness and overall safety.
Sleep and Symptom Research in Women’s Health
The clinical trials at Anima explore how menopause can affect sleep and daily well-being, especially in women affected by sleep disturbances associated with menopause. This research aims to support better diagnosis and treatment options by examining whether a targeted therapy can improve sleep quality.
- Sleep quality during menopause
- Women’s health research
- Testing treatment effectiveness
These studies contribute to a clearer understanding of menopause-related symptoms and may help guide more effective care for patients seeking relief from ongoing sleep disruption.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 11 therapeutic areas and 15 of 62 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 62 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 14 by active trials.
- 1Eli Lilly & Co.3active
lock +13 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eli Lilly & Co.5trials
lock +9 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Anima
lock Showing 1 of 37 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 1 | Alkermes Inc. | Phase II | Not Recruiting | Jan 2025 | Jul 2025 |
IMP list
lock Showing 1 of 62 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Alks 2680 | 4 | Unknown | 2025-01-17 | 2025-08-26 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.